Keywords
How to Cite
Cited by
Abstract
In 2019, a new infection was reported in China. This coronavirus was named SARS-COV-2, causative of the 21st-century pandemic, COVID-19. Health systems adopted different strategies to cope with it.
Objective: to describe the clinical-epidemiological characteristics of COVID-19 in children seen at an Emergency Febril Unit (UFU).
Patients and Method: Cross-sectional study in patients under 18 years of age tested for SARS-COV-2 between April 1 and June 30, 2020. All epidemiological records made at the time of consultation and the result of the Polymerase Chain Reaction (PCR) test of these patients, either by suspicion of COVID-19 or epidemiological isolation criteria, were included. Patients whose samples had been taken for SARS-COV-2 determination outside the initial time of consultation or whose epidemiological records were incomplete or did not meet the established inclusion criteria were excluded. The diagnosis of COVID-19 was made using the PCR technique for SARS-COV-2 in nasopharyngeal secretions obtained by nasopharyngeal swab or aspirate. The following variables were recorded: age, gender, place of residence, history of close contact, history of history of close contacts, travel history and comorbidities, history of institutionalization and PCR result.
Results: 1,104 patients were admitted to the UFU and tested due to suspected COVID-19. 152 patients had to be excluded due to insufficient data. Of the 952 patients tested, 22.6% had a detectable result, and 71.2% of them reported close contact with confirmed cases. The mean age was 5.9 years. The 55.4% were male and 99.3% lived in the Metropolitan Area of Buenos Aires. 72.8% of the patients tested had symptoms. The time of delay in consultation was 2.17 days. 25% of the children had comorbidities.
Conclusions: The availability of the UFU facilitated access and optimized the care circuit in response to demand. Children with a history of close contact and those symptomatic showed more frequently a detectable result for SARS-COV-2.
Los contenidos publicados en esta revista están protegidos bajo una Licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0). Esto significa que cualquier persona es libre de compartir, usar y construir a partir de este artículo, incluso con fines comerciales, siempre que se otorgue el crédito apropiado al autor original, se proporcione un enlace a la licencia, se indique el nombre y edición de la Revista.
Esta licencia no impone restricciones adicionales, lo que garantiza la libre circulación y reutilización del conocimiento con respeto y transparencia hacia los derechos de los autores. (Véase El efecto del acceso abierto).